BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Synthetic Biologics, Inc. (SYN)' Academic Collaborator To Present Novel Monoclonal Antibody Combination For Treating Whooping Cough (Pertussis) At Gordon Research Conference 7/21/2014 12:00:48 PM
Synthetic Biologics, Inc. (SYN) Forms Clinical Advisory Board to Support Novel C. difficile Preventative Program 6/30/2014 9:53:20 AM
Synthetic Biologics, Inc. (SYN) Reports That Licensor Cedars-Sinai Medical Center Finds Eradication Of Gut Methane Improves Insulin Sensitivity And Lipid Profiles In Study Of Pre-Diabetic, Obese Patients 6/25/2014 6:36:24 AM
Synthetic Biologics, Inc. (SYN) To Present At The 3rd Annual Marcum LLP Microcap Conference 5/21/2014 6:15:54 AM
Synthetic Biologics, Inc. (SYN) Reports First Quarter 2014 Financial Results And Operational Highlights 5/15/2014 7:27:06 AM
Synthetic Biologics, Inc. (SYN) Announces Recent International Patents That Bolster Its C. Difficile Program 5/8/2014 9:05:38 AM
Synthetic Biologics, Inc. (SYN) To Discuss Phase II Results Of Oral Estriol Candidate Trimesta™ For Relapsing-Remitting Multiple Sclerosis In Women 4/30/2014 9:51:19 AM
Synthetic Biologics, Inc. (SYN) Reports University of California, Los Angeles (UCLA) Announcement Of Preliminary Positive Topline Efficacy And Safety Results From Investigator-Led Phase 2 Study Of Trimesta™ For Relapsing-Remitting Multiple Sclerosis 4/29/2014 3:53:28 PM
Synthetic Biologics, Inc. (SYN)' Reports Preclinical Data To Support Clinical Development Of Novel Pertussis Therapeutic 4/23/2014 9:01:34 AM
Synthetic Biologics, Inc. (SYN) Appoints Mark Pimentel, M.D., Chairman Of New Irritable Bowel Syndrome Clinical Advisory Board 4/14/2014 6:15:29 AM
12345678910...